Benzathine Penicillin Intramuscular Injection manufacturers & suppliers

Benzathine Penicillin Intramuscular Injection

Form: Intramuscular Injection

Strength: 600,000 units / mL; 1.2 million units / mL

Reference Brands: Bicillin L-A, Bicillin C-R(US)

Category: Antibiotics

Benzathine penicillin IM injection is approved in the US and EU for treating syphilis, rheumatic fever, and streptococcal infections. In the US, brands like Bicillin L-A are regulated by the FDA, supported by dossiers demonstrating safety, efficacy, and manufacturing standards, with strict guidelines due to antibiotic resistance. In the EU, approval depends on national regulations, with dossiers required to demonstrate quality and safety. Both regions enforce stringent prescribing, storage, and usage regulations. For expert assistance with regulatory dossiers, compliance, and registration, visit PharmaTradz. We support seamless market access, ensuring adherence to European and US standards for safe, effective antibiotic therapy while navigating complex regulatory landscapes seamlessly.

Get Enquiry Back to Listing
Disclaimer: By continuing to browse, you agree to the terms of use of this website and the Trade Marks displayed, in compliance with the provisions of the Trademark Act, 1999, Section 30 and 30(1) under 'Fair use.'

The Trade Mark owner has been correctly identified under the heading Manufacturer / TM Owner as required by the Act.

Related Products

Colistin (Polymyxin E) Inhalation Solution (Nebulizer)

Strength: 75 mg/2 mL

Form: Inhalation Solution (Nebulizer)

Reference Brands: Coly-Mycin M(US)

View Details
Colistin (Polymyxin E) Injectable

Strength: 150 mg/5 mL, 300 mg/5 mL, 1.5 million IU/vial

Form: Injectable (IV/IM/SC)

Reference Brands: Coly-Mycin M(US)

View Details
Fosfomycin Oral Sachets Or Powder For Suspension

Strength: 3g in a sachet

Form: Oral Sachets or Powder for Suspension

Reference Brands: Zyflo(US)

View Details
Fosfomycin Iv

Strength: 2 g, 4g per vial

Form: Intravenous (IV)

Reference Brands: Zyflo(US)

View Details

Subscribe to Our Newsletter

Stay updated on pharma trends and marketplace opportunities.

This website uses cookies to ensure you get the best experience. By using our site, you agree to our Privacy Policy.